Close this search box.

The State of Lung Cancer in KY Part 3: Emerging Treatments, New Research and the Incorporation of Palliative Care in Lung Cancer

Continuing Medical Education Information

Course Description:

This module will discuss emerging treatments in lung cancer, explore the benefits of lung cancer screening and the current utilization in Kentucky.  Discussion will also focus on palliative care and developing an understanding of when to refer patients for care.

Statement of Need:

The American Lung Association released it’s 2021 “State of Lung Cancer” report  that shows “that Kentucky has the highest incidence rate in the US, incidence refers to the number of new cases of lung cancer in each state.
51 in the nation (last) for lung cancer incidence at 89.4 per 100,000 people. Incidence refers to the number of new cases of lung cancer in each state. The national lung cancer incidence is 57.7 per 100,000 people.

  • 41 in the nation (bottom) for survival at 29.3%. The national average of people alive five years after a lung cancer diagnosis is 23.7%.”

At the end of this module physicians will be able to:

  • Define Palliative Care
  • Identify patients that may benefit from Palliative Care
  • Encourage patients with lung cancer to receive new treatment modalities and enroll in trials
  • Describe emerging treatments associated with lung cancer
  • Describe status and utilization of lung cancer screening in Kentucky


The following planners disclose that they have no relevant relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

  • Heather Lathan
  • Miranda Mosley
  • Emily Schott

The following speaker discloses that she has nothing to disclose:

  • Laura Trice, MD

The following speaker discloses the following:

  • Goetz Kloecker, MD, MSPH, MBA
    • Astra Zeneca, Genentech: Advisor, speaker
    • BMS: Advisor, speaker, research
    • Novartis, Amgen/Merch, Guardant/Caris: Speaker

All relevant financial relationships listed above have been mitigated.

Commercial Support: There is no commercial support associated with this activity.

Accreditation and Designation:
The Kentucky Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Kentucky Medical Association designates this internet enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Target Audience: Physicians in the Commonwealth of Kentucky

Estimated Time to Complete: This module will take approximately 1.0 hour to complete

Method of Participation Used: Participants will view and listen to a recorded lecture while simultaneously viewing slides.

Hardware/Software Requirements: High speed internet connection

Faculty: Goetz Kloecker, MD; MSPH, MBA; Laura Trice, MD

Meeting Planner: Miranda Mosley, Heather Lathan

Provider Contact Information: Miranda Mosley, Kentucky Medical Association

Copyright: There is no copyright associated with this activity

Release Date: February 2022

Termination Date: February 2023

Click here to access the activity